You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Bulk Pharmaceutical API Sources for NORETHINDRONE ACETATE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for NORETHINDRONE ACETATE

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free N6127_SIGMA ⤷  Get Started Free
TCI (Tokyo Chemical Industry) ⤷  Get Started Free N0450 ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-003-901-032 ⤷  Get Started Free
TimTec ⤷  Get Started Free ST075199 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for NORETHINDRONE ACETATE

Last updated: July 28, 2025

Introduction

Norethindrone acetate (NORA) is a synthetic progestin extensively used in hormonal contraceptives, hormone replacement therapy, and treatment of gynecological disorders. As a critical component in various pharmaceutical formulations, the procurement of high-quality bulk API is vital for manufacturers to ensure drug efficacy, safety, and regulatory compliance. Sourcing reliable bulk NORA suppliers involves evaluating their manufacturing capabilities, quality standards, regulatory adherence, and supply chain stability. This article provides an in-depth analysis of prominent sources for bulk Norethindrone Acetate, focusing on global manufacturers, contract manufacturing organizations (CMOs), and key considerations for procurement.

Overview of Norethindrone Acetate Production

Producing NORA requires specialized chemical synthesis processes, including asymmetric synthesis and rigorous purification. The API demands strict quality controls — including impurity profiling, potency, and stability testing — to meet standards such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and other regional guidelines.

Manufacturers typically operate Good Manufacturing Practices (GMP) facilities, often certified by regulatory authorities such as the FDA, EMA, or equivalents. These facilities are equipped with advanced chemistry lab setups, quality control laboratories, and quality assurance protocols tailored to produce APIs compliant with international standards.

Major Sources of Norethindrone Acetate API

1. Indian API Manufacturers

India hosts a robust pharmaceutical industry with multiple companies specializing in hormonal APIs, including NORA.

  • Glenmark Pharmaceuticals
    Glenmark is a leading global pharmaceutical company with extensive API manufacturing facilities. The company's API division produces high-quality NORA, adhering to global regulatory standards. Their manufacturing plants in India are GMP-certified, offering reliable supply chains for international clients.

  • Fresenius Kabi India
    Known for formulating and manufacturing active ingredients for various therapeutic areas, Fresenius Kabi maintains a GMP-compliant facility producing NORA APIs, primarily for export markets.

  • Aurobindo Pharma
    A prominent Indian manufacturer of generic APIs, Aurobindo’s facilities are FDA-approved and supply NORA for both generic and branded formulations.

  • Hikma Pharmaceuticals (India)
    Hikma operates manufacturing units in India complying with global standards, with proven expertise in steroidal APIs, including NORA.

2. Chinese API Manufacturers

China remains a significant source for bulk APIs owing to its large-scale manufacturing capacity and competitive pricing.

  • Jiangsu Hengrui Medicine Co., Ltd.
    Hengrui is among China's leading pharmaceutical innovators, with a GMP-compliant facility producing hormonal APIs, including NORA, for supply to global markets.

  • Shanghai Fosun Pharmaceutical
    Fosun's API manufacturing arm produces NORA under strict quality control aligned with international standards.

  • Zhejiang Jiuxing Biotech
    Specializes in steroid hormone synthesis, offering high-purity NORA API suitable for pharmaceutical use.

3. European and North American API Suppliers

While Europe and North America have a smaller number of API producers relative to Asia, some companies maintain stringent quality and regulatory standards.

  • BASF (Germany)
    As an industry leader, BASF develops and supplies high-quality specialty APIs, including hormonal compounds, with stringent regulatory compliance.

  • Thermo Fisher Scientific (United States)
    Offers API development, manufacturing, and custom synthesis services, including components like NORA for pharmaceutical companies.

  • Lonza (Switzerland)
    Known for custom manufacturing and high-quality chemical synthesis, Lonza provides NORA APIs to clients requiring robust regulatory adherence.

4. Contract Manufacturing Organizations (CMOs)

CMOs act as intermediaries, providing API synthesis, purification, and supply services to pharmaceutical firms. Engaging with reputable CMOs helps ensure supply chain resilience.

  • Dr. Reddy’s Laboratories
    A top Indian CMO specializing in hormone APIs, including NORA, with comprehensive quality assurance protocols.

  • Hovione (Portugal)
    Offers API manufacturing, including hormonal APIs, with a focus on process development and supply chain reliability.

  • Cambrex Corporation (United States)
    Provides contract manufacturing and API development, emphasizing high purity and regulatory compliance for APIs such as NORA.

Evaluation Criteria for API Suppliers

When selecting a supplier for Norethindrone Acetate API, consider the following:

  • GMP Certification and Regulatory Compliance
    Suppliers must maintain GMP certification from recognized authorities (FDA, EMA) to ensure quality and regulatory acceptance.

  • Quality Assurance and Testing
    Strict impurity profiling, potency testing, stability data, and adherence to pharmacopoeial standards (USP, EP).

  • Manufacturing Capacity and Lead Times
    Capacity should meet forecasted demand with well-defined lead times for consistent supply.

  • Pricing and Payment Terms
    Competitive pricing without compromising quality; flexible payment terms preferred for long-term relationships.

  • Supply Chain Stability
    Robust logistics and contingency plans to avoid shortages or delays.

  • Geo-Political and Regulatory Factors
    Compliance with export/import regulations, trade policies, and regional restrictions.

Regulatory Considerations

Exporting and importing NORA require thorough understanding of regional drug registration and import regulations. Manufacturers must ensure that APIs meet pharmacopoeial specifications and comply with documentation requirements such as Certificates of Analysis (CoA), Certificates of Pharmaceutical Product (CPP), and other regulatory dossiers.

Emerging Trends and Market Dynamics

The global API market for NORA is influenced by factors including fluctuating raw material prices, advances in green chemistry (reducing environmental impact in synthesis), and regional regulatory reforms. The rise of biosimilar and generic hormone therapies continues to drive demand, emphasizing the importance of reliable, high-quality API sourcing.

The COVID-19 pandemic underscored the necessity for diversified supply chains, prompting many pharma companies to seek multiple sources across geographies to mitigate risks.

Conclusion

Efficient procurement of bulk Norethindrone Acetate APIs is crucial for pharmaceutical companies aiming to sustain high-quality, cost-effective formulations. Indian and Chinese API manufacturers dominate the global supply landscape, offering competitive options with GMP certification and regulatory compliance. European and North American suppliers cater to the high-end market segments emphasizing quality and regulatory adherence.

Establishing strategic partnerships with reputable manufacturers, monitoring regulatory trends, and ensuring strict quality controls are key to securing reliable and compliant API sources for NORA.


Key Takeaways

  • Indian and Chinese API manufacturers are primary sources for bulk Norethindrone Acetate, offering cost-effective and GMP-compliant options.
  • European and North American API providers emphasize stringent quality standards, suitable for high-regulatory markets.
  • Selection criteria should prioritize GMP certification, quality assurance processes, supply capacity, and regulatory compliance.
  • Contract manufacturing organizations enhance supply chain resilience and provide customized synthesis services.
  • Continuous market monitoring and adherence to regulatory changes are essential for maintaining a stable, compliant API supply chain.

FAQs

1. What factors should I consider when sourcing Norethindrone Acetate APIs?
Key factors include GMP certification, impurity profiles, manufacturing capacity, regulatory compliance, pricing, and supply chain stability.

2. Are Indian API manufacturers reliable for sourcing NORA?
Yes, many Indian manufacturers are GMP-certified, FDA-approved, and have extensive experience producing hormonal APIs for global markets.

3. How do Chinese APIs compare quality-wise with Western suppliers?
Chinese APIs often meet international standards when sourced from established, GMP-certified manufacturers with rigorous quality controls.

4. What regulatory documents are essential for importing NORA API?
Typical requirements include Certificates of Analysis (CoA), Certificates of Pharmaceutical Product (CPP), and documentation demonstrating compliance with pharmacopeial standards.

5. Can I use API suppliers as strategic partners for long-term supply?
Yes, establishing long-term relationships with reputable suppliers enhances supply stability, ensures quality consistency, and may offer better pricing terms.


Sources:

  1. [1] U.S. Pharmacopeia. Norethindrone Acetate Monograph.
  2. [2] Indian Drug Regulatory Authority. GMP certification standards.
  3. [3] European Medicines Agency. API manufacturing guidelines.
  4. [4] Global Chemical Suppliers. Directory of hormonal API manufacturers.
  5. [5] Market analysis reports on hormonal APIs (2022-2023).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.